Abstract
on endotoxemia-induced AKI in mice.
23
Injection of LPS (3 mg/kg; i.p.) decreased glomerular filtration rate (GFR) and the amount of thromboxane, for example, may play an important role in septic AKI (5, 18, 40, 72 
83
We investigated therefore the impact of COX-1 and COX-2 activity for the increased 84 formation of TxA 2 in response to LPS, which is an experimental approach commonly used in 85 examining the pathogenesis of septic AKI. We used a low, nonlethal dose, which has been 86 found to induce AKI in the absence of severe hypotension (39). Because glomerular filtration 87 rate decreases shortly after the injection of endotoxin (12) 
MATERIALS AND METHODS

97
Animal experiments
98
All animal experiments were performed according to the National Institutes of Health Guide 99 for the Care and Use of Laboratory Animals and were approved by the local ethics committee.
100
Male C57BL/6J mice (8 weeks old) were obtained from Charles River (Sulzfeld, Germany).
101
Mice were acclimated for at least one week in the animal facility with free access to food and Sigma Aldrich Chemical, Germany) was given orally 48, 24 and 2h prior to injection of LPS.
113
The animals (n=6-12 per group) were killed 4, 8 or 16h after injection of LPS or saline during previous studies demonstrating inhibition of constitutive prostaglandin synthesis (16, 25, 45) .
119
The selectivity for SC-560 (COX-1 inhibitor) and SC-236 (COX-2 inhibitor) has been 120 previously established (55, 65, 71) . Therefore, it seems unlikely that SC560 is inhibiting both COX 121 isoforms at the dose used in our study. However, since it has been reported that SC-560 may act at 122 least in some cell types as an unselective COX inhibitor (13), we cannot exclude a small effect of SC-123 560 on COX-2 activity. 124
Measurement of Renal and Blood Parameters
125
GFR was calculated from FITC-sinistrin plasma clearance (60). In brief, three hours after the 126 injection of LPS or isotonic saline 3.7µl/g BW of FITC-sinistrin (1.5% wt/wt dissolved in 127 0.9% NaCl) was injected into the retroorbital plexus during brief isoflurane anesthesia from 128 which the animals recovered within ∼20 s. At 3, 7, 10, 15, 35, 55 , and 75 min after the 129 injection, mice were placed in a restrainer, and 2 μl of blood were drawn from the tail vein 130 using a 30-g atraumatic needle. Samples were centrifuged and 500 nl of plasma were 131 transferred into a microcapillary and diluted 1:10 in 500 mmol HEPES (pH 7.4). To generate 132 a standard curve, 1 μl of 1.5%-FITC-sinistrin was diluted 1:100, 1:500, and 1:1000 and 
Protein preparation and immunoblotting
158
Protein preparation and immunoblotting were performed as described previously (32). In 
241
In addition, we investigated plasma urea levels. Neither the COX-1 inhibitor SC-560 nor the 242 COX-2 inhibitor SC-236 altered basal plasma urea levels (Fig. 4C) . Four hours after injection 243 of LPS plasma urea concentration increased from 24 ±2 to 36 ±2 mg/dl. Inhibition of COX-1 244 attenuated the LPS-induced increase in plasma urea and COX-2 inhibition enhanced the LPS-245 induced rise in plasma urea concentration at 4 hours after LPS-injection (P < 0.05; Fig. 4B ).
247
Effect of clopidogrel pretreatment on LPS-induced decrease in platelet count and GFR
248
We further investigated the effect of clopidogrel, which has been shown to attenuate the fall 249 in platelet count and to improve end organ damage in animal models of sepsis (26, 62).
250
Therefore, we pretreated mice with the P2Y 12 receptor antagonist clopidogrel. Clopidogrel 251 inhibited the LPS-induced drop in platelet count (n = 6, P < 0.05) but did not attenuate the 252 LPS-induced increase in plasma TxB 2 levels or the LPS-induced decrease in GFR (Fig. 5) .
254
Effect of SC-560 on LPS-induced renal inflammation
255
To investigate the effect of SC-560 on renal inflammation, we determined the renal mRNA 256 abundance of IL-1β and TNFα. We found, that renal IL-1β mRNA abundance was increased 257 about 4-fold 4 hours after the injection of LPS (n = 6, P < 0.05). SC-560 did not alter basal 258 and LPS-induced levels of IL-1β (Fig. 6A) . Further, renal TNFα mRNA abundance was 259 increased about 7-fold 4 hours after the injection of LPS (n = 6, P < 0.05). SC-560 did not 260 alter basal or LPS-induced levels of TNFα (Fig. 6B) .
262
Discussion
263
In the present study, we demonstrate that SC-560, an experimental COX-1 inhibitor, inhibited 
267
In line with previous observations, we found that renocortical COX-2 expression was strongly 
296
There is growing evidence that LPS exerts a direct effect on platelets. It has been reported that 
334
Our data indicate that COX-1 is responsible for the increased formation of TxA 2 in response 335 to LPS. Therefore, we investigated the effect of SC-560 on endotoxemia-induced acute 336 kidney injury. Neither COX-1 nor COX-2 inhibition affected GFR in control mice as 337 described before (15). We now found that inhibition of COX-1 attenuated the early decrease 
341
Similarly to these reports, the endotoxemia-induced decrease in GFR in our present study was 
356
A limitation of our study is that neither blood pressure nor renal blood flow were measured. In Indeed, it has been found, that an intravenous dose of 2 mg/kg LPS reduces blood pressure 364 from 106 mmHg to about 75 mmHg 6h after the injection of LPS in conscious freely moving mice 365 (66). Recently, we determined blood pressure in endotoxemic mice by radio-telemetry. In this 366 study, we found that one hour after intraperitoneal injection of LPS at a dose of 3 mg/kg MAP 367 dropped significantly from 104 to 93 mmHg. However, during the following two to three 
